- Home
- ICUI vs COMP Comparison
ICUI vs COMP Comparison
Compare ICUI & COMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- COMP
- Stock Information
- Founded
- ICUI 1984
- COMP 2012
- Country
- ICUI United States
- COMP United States
- Employees
- ICUI N/A
- COMP N/A
- Industry
- ICUI Medical/Dental Instruments
- COMP EDP Services
- Sector
- ICUI Health Care
- COMP Technology
- Exchange
- ICUI Nasdaq
- COMP Nasdaq
- Market Cap
- ICUI 3.6B
- COMP 4.3B
- IPO Year
- ICUI 1992
- COMP 2021
- Fundamental
- Price
- ICUI $138.67
- COMP $7.29
- Analyst Decision
- ICUI Buy
- COMP Buy
- Analyst Count
- ICUI 4
- COMP 6
- Target Price
- ICUI $199.67
- COMP $10.75
- AVG Volume (30 Days)
- ICUI 339.0K
- COMP 7.7M
- Earning Date
- ICUI 05-06-2025
- COMP 05-07-2025
- Dividend Yield
- ICUI N/A
- COMP N/A
- EPS Growth
- ICUI N/A
- COMP N/A
- EPS
- ICUI N/A
- COMP N/A
- Revenue
- ICUI $2,382,046,000.00
- COMP $5,629,100,000.00
- Revenue This Year
- ICUI $0.84
- COMP $28.62
- Revenue Next Year
- ICUI $2.91
- COMP $13.58
- P/E Ratio
- ICUI N/A
- COMP N/A
- Revenue Growth
- ICUI 5.44
- COMP 15.23
- 52 Week Low
- ICUI $93.36
- COMP $3.03
- 52 Week High
- ICUI $196.26
- COMP $10.25
- Technical
- Relative Strength Index (RSI)
- ICUI 45.36
- COMP 35.57
- Support Level
- ICUI $136.61
- COMP $7.04
- Resistance Level
- ICUI $145.82
- COMP $7.91
- Average True Range (ATR)
- ICUI 10.06
- COMP 0.56
- MACD
- ICUI 0.10
- COMP -0.13
- Stochastic Oscillator
- ICUI 38.37
- COMP 12.47
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About COMP Compass Inc.
Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.